SGO

SONORO GOLD ANNOUNCES $0.5 MILLION PRIVATE PLACEMENT

Retrieved on: 
Thursday, October 6, 2022
IS, SGO, Gold, GOLD, Company, TSX Venture Exchange, Board, Unit, GLOBE, Offering, Record, Security (finance)

VANCOUVER, Canada, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to announce that it will undertake a non-brokered private placement offering (the "Offering") consisting of up to 3,500,000 units (the “Units”) at a price of C$0.15 per Unit, for gross proceeds of up to C$525,000.  

Key Points: 
  • Each Unit will be composed of one Sonoro common share and one common share purchase warrant.
  • Each warrant will entitle the holder thereof to purchase one additional Sonoro common share for a period of two years from the closing of the private placement at an exercise price of C$0.225 per share.
  • Sonoro Gold Corp. is a publicly listed exploration and development Company holding the near-development-stage Cerro Caliche project and the exploration-stage San Marcial project in Sonora State, Mexico.
  • On behalf of the Board of SONORO GOLD CORP.

SONORO GOLD REPORTS UNDERGROUND CHANNEL SAMPLING PROGRAM AT CERRO CALICHE INCLUDING 2.0 METERS OF 7.863 GRAMS OF GOLD PER TONNE

Retrieved on: 
Monday, August 15, 2022
Hand, CEO, GLOBE, National instrument, Board, Mouth, SGO, National Instrument 43-101, Acid, Company, Program, QA/QC, Market segmentation, News, Gold, Record, Uranium, Mining, Wood drying

Samples were obtained from a historic underground tunnel at the Cabeza Blanca mineralized gold zone, located in the southwestern part of the property.

Key Points: 
  • Samples were obtained from a historic underground tunnel at the Cabeza Blanca mineralized gold zone, located in the southwestern part of the property.
  • An electric rotary handheld saw was used to acquire 34 quality continuous channel samples of vein and breccia material.
  • Highlights include 2.0 meters averaging 7.863 grams of gold per tonne (g/t Au) across the vein with 3.5 meters averaging 3.071 g/t Au over the five saw cuts along the vein segment.
  • Sonoro Gold Corp. is a publicly listed exploration and development Company holding the near-development-stage Cerro Caliche project and the exploration-stage San Marcial project in Sonora State, Mexico.

Marsai Martin Teams Up with the Foundation for Women's Cancer to Raise Awareness of Gynecologic Cancer as Move4Her Celebrity Ambassador

Retrieved on: 
Tuesday, August 2, 2022
Message, Oncology nursing, SGO, Universal, Diagnosis, Cancer, Education, Awareness, Walking, FWC, Physician, Society of Gynecologic Oncology, Twitter, Instagram, Foundation, Woman, Memorial Sloan Kettering Cancer Center, Research, Health, Ginger, Risk, Cervical cancer, Movement, Society, Vulvar cancer, MD, Patient, ABC, Gynecologic Oncology (journal), Black-ish, Birth control, Medicine, Facebook

CHICAGO, Aug. 2, 2022 /PRNewswire-PRWeb/ -- The Foundation for Women's Cancer (FWC) is pleased to announce that Marsai Martin, known for her roles in the ABC sitcom Black-ish and Universal's Little, will be a Celebrity Ambassador for Move4Her. Now in its third year, Move4Her is the FWC's primary fundraising event to power research and awareness of the five gynecologic (gyn) cancers – cervical, ovarian, uterine/endometrial, vaginal or vulvar cancer. For the first time, this year Move4Her will be a Month of Movement held throughout September for Gynecologic Cancer Awareness Month.

Key Points: 
  • Actress Marsai Martin, whose grandmother battled cervical cancer, partners with the Foundation for Women's Cancer for its annual fundraising initiative Move4Her to power research and awareness of gynecologic cancers.
  • CHICAGO, Aug. 2, 2022 /PRNewswire-PRWeb/ -- The Foundation for Women's Cancer (FWC) is pleased to announce that Marsai Martin, known for her roles in the ABC sitcom Black-ish and Universal's Little, will be a Celebrity Ambassador for Move4Her.
  • For the first time, this year Move4Her will be a Month of Movement held throughout September for Gynecologic Cancer Awareness Month.
  • The Foundation for Women's Cancer (FWC) is dedicated to increasing public awareness of gynecologic cancer risk, prevention, early detection, and optimal treatment.

SONORO ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING

Retrieved on: 
Thursday, July 7, 2022
TSX Venture Exchange, Exploration, SGO, GOLD, GLOBE, Professional Football Compensation Committee, Corporation, Gold, Company, Record, Meeting, Compensation, Board, Security (finance), Management, BC, Operation

VANCOUVER, Canada, July 07, 2022 (GLOBE NEWSWIRE) -- Sonoro Gold Corp., (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP), (Sonoro and the Company), announces the results of its Annual General Meeting of Shareholders (the Meeting) held June 30, 2022, in Vancouver, BC.

Key Points: 
  • VANCOUVER, Canada, July 07, 2022 (GLOBE NEWSWIRE) -- Sonoro Gold Corp., (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP), (Sonoro and the Company), announces the results of its Annual General Meeting of Shareholders (the Meeting) held June 30, 2022, in Vancouver, BC.
  • At the Meeting, shareholders approved all resolutions put before them by management including the election of all director nominees, the re-appointment of the auditors and the approval of the Company's new share option plan.
  • The shareholders voted to re-elected John M. Darch, Kenneth MacLeod, Neil Maedel, Stephen Kenwood, James Taylor, and Curtis Turner to serve as directors of the Company until the next annual meeting of the shareholders.
  • Following the Meeting, the Board appointed Kenneth MacLeod, Stephen Kenwood and Curtis Turner to its Audit and Compensation Committees.

R. Stuart Angus Discloses Investment in Sonoro Gold Corp.

Retrieved on: 
Tuesday, July 5, 2022
TSX Venture Exchange, SEDAR, Unit, SGO, GLOBE, Exercise, Acquisition, Security (finance), Corporation

Each Unit consists of one Corporation common share (each a Share) and one Share purchase warrant (each a Warrant).

Key Points: 
  • Each Unit consists of one Corporation common share (each a Share) and one Share purchase warrant (each a Warrant).
  • Each Warrant entitles the holder to acquire one additional Share at an exercise price of $0.225 per Share for a period of two years.
  • Prior to the Acquisition R. Stuart Angus beneficially owned or controlled 6,719,667 Shares and 5,508,667 warrants of the Corporation.
  • The Units were acquired by R. Stuart Angus for investment purposes.

SONORO GOLD ANNOUNCES CLOSING OF OVERSUBSCRIBED $3 MILLION NON-BROKERED PRIVATE PLACEMENT

Retrieved on: 
Monday, July 4, 2022
TSX Venture Exchange, Multilateral, Unit, Offering, SGO, CEO, Minority, Cerro, GLOBE, Officer, Program, Â, Company, Gold, Record, Mining, PI, Policy, Board, MI, Security (finance), Risk management, Finder

Each Unit consists of one Sonoro Common Share and one Share Purchase Warrant.

Key Points: 
  • Each Unit consists of one Sonoro Common Share and one Share Purchase Warrant.
  • Each warrant entitles the holder to purchase one additional Sonoro Common Share for a period of two years from the closing date at an exercise price of $0.225 per share.
  • All securities issued and issuable in connection with the Offering will be subject to a 4-month plus one day hold period ending October 31, 2022.
  • On behalf of the Board of Sonoro Gold Corp.

SONORO FILES UPDATED PRELIMINARY ECONOMIC ASSESSMENT ON SEDAR

Retrieved on: 
Friday, June 24, 2022
Technical report, GLOBE, USD, Engineering design process, Foodservice Equipment & Supplies, PEA, Industry, Nature, Silver, National Instrument 43-101, Qualified person (European Union), Company, SGO, Mining, Gold, Competence, Micon, This Life of Mine, Project, Commission, Record, News, Construction management, Board, National instrument, Integration competency center, Integrity, Uranium, Independence, Engineering

VANCOUVER, Canada, June 23, 2022 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (Sonoro or the Company) is pleased to report the filing of a technical report titled Updated Preliminary Economic Assessment of the Cerro Caliche Project, Sonora, Mexico (the PEA) with an effective date of May 9, 2022.

Key Points: 
  • VANCOUVER, Canada, June 23, 2022 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (Sonoro or the Company) is pleased to report the filing of a technical report titled Updated Preliminary Economic Assessment of the Cerro Caliche Project, Sonora, Mexico (the PEA) with an effective date of May 9, 2022.
  • Initial CAPEX costs of USD $26 million, including USD $3 million in contingency
    Note: All currencies are reported in U.S. dollars.
  • The new geological data is to be included in an updated resource estimate scheduled to be filed in the fall of 2022.
  • The potential economic impact of the updated resource on the proposed heap leach mining operation will be contemplated in a further technical report.

Inaugural NHTSA ADS Crash Data Release Shows Embark With Perfect Safety Record

Retrieved on: 
Thursday, June 16, 2022
NHTSA, Industry, National Highway Traffic Safety Administration, Safety, Advanced driver-assistance systems, Technology, Unlikely Heroes, Crash, Compliance, Efficiency, AV, Engineering, Build automation, ADS, Partner, ADAS, CA, Map (higher-order function), Nasdaq, SGO, History, Death, Software, COO, Hospital, FMCSA, SAN, GLOBE, VMF, Road, Rail transport, Embark

SAN FRANCISCO, June 16, 2022 (GLOBE NEWSWIRE) -- Embark Trucks, Inc. (Nasdaq: EMBK, Embark), a leading developer of autonomous technology for the trucking industry, emerged with a perfect safety record in new data reported by the National Highway Traffic Safety Administration (NHTSA) yesterday.

Key Points: 
  • SAN FRANCISCO, June 16, 2022 (GLOBE NEWSWIRE) -- Embark Trucks, Inc. (Nasdaq: EMBK, Embark), a leading developer of autonomous technology for the trucking industry, emerged with a perfect safety record in new data reported by the National Highway Traffic Safety Administration (NHTSA) yesterday.
  • Embark reported zero crashes since NHTSA began collecting data last year, and has never had a NHTSA-reportable crash in its history.
  • Since its founding in 2016, Embark has never been involved in a NHTSA- or FMCSA-reportable crash.
  • Embark sets a high standard for the industry on operational safety and compliance, and the NHTSA data release is a testament to the work performed every day by our engineering and operations team, said Stephen Houghton, COO of Embark.

SONORO GOLD ANNOUNCES $2 MILLION PRIVATE PLACEMENT

Retrieved on: 
Monday, June 6, 2022
Company, Offering, Unit, TSX Venture Exchange, IS, Record, GOLD, GLOBE, Gold, Board, SGO, Security (finance)

VANCOUVER, Canada, June 06, 2022 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to announce that it will undertake a non-brokered private placement offering (the "Offering") consisting of up to 13,500,000 units (the “Units”) at a price of C$0.15 per Unit, for gross proceeds of up to C$2,025,000.

Key Points: 
  • Each Unit will be composed of one Sonoro common share and one common share purchase warrant.
  • Each warrant will entitle the holder thereof to purchase one additional Sonoro common share for a period of two years from the closing at an exercise price of C$0.225 per share.
  • Sonoro Gold Corp. is a publicly listed exploration and development Company holding the near-development-stage Cerro Caliche project and the exploration-stage San Marcial project in Sonora State, Mexico.
  • On behalf of the Board of SONORO GOLD CORP.

ImmunoGen Presents Additional Efficacy and Safety Analyses Evaluating Mirvetuximab Soravtansine in Ovarian Cancer at ASCO

Retrieved on: 
Thursday, May 26, 2022
Oncology, Health, FDA, General Health, Clinical Trials, Pharmaceutical, Biotechnology, Senior, Trae tha Truth, Population, Nausea, Annual general meeting, Financial toxicity, Gynecologic Oncology (journal), OS, Survival, SGO, ImmunoGen, Progression-free survival, DCR, Patient, Poster, Priority review, Society of Gynecologic Oncology, Control, ORR, Bevacizumab, Society, McGovern Medical School, American Society of Clinical Oncology, DOR, FDA, PFS, Dana–Farber Cancer Institute, IMGN, Safety, Division, ASCO, Ovarian cancer, Harvard Medical School, NR, CR, Cancer, Diarrhea, Fatigue, Corneal ulcer, Pharmaceutical industry, Medical imaging, Synthetic rubber, Medicine, MD

ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced additional efficacy data from the pivotal SORAYA study evaluating mirvetuximab soravtansine (mirvetuximab) monotherapy in patients with folate receptor alpha (FR)-high platinum-resistant ovarian cancer who have been previously treated with Avastin (bevacizumab) and an integrated safety summary of single-agent mirvetuximab across multiple studies in patients with FR-positive recurrent ovarian cancer.

Key Points: 
  • ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced additional efficacy data from the pivotal SORAYA study evaluating mirvetuximab soravtansine (mirvetuximab) monotherapy in patients with folate receptor alpha (FR)-high platinum-resistant ovarian cancer who have been previously treated with Avastin (bevacizumab) and an integrated safety summary of single-agent mirvetuximab across multiple studies in patients with FR-positive recurrent ovarian cancer.
  • SORAYA enrolled 106 platinum-resistant ovarian cancer patients with high FR expression who have been previously treated with 1 to 3 prior systemic treatments, at least one of which included bevacizumab.
  • If approved, I look forward to being able to offer mirvetuximab to my patients and continuing to support its further development in patients with ovarian cancer."
  • ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.